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ABSTRACT
Objective To explore clinical characteristics in individuals
with patellofemoral osteoarthritis (PFOA) compared to
individually-matched asymptomatic controls. We also
explored associations between functional performance and
patient-reported symptoms with patellofemoral alignment.
Methods We assessed 15 individuals with PFOA and 15
individually-matched asymptomatic controls. In addition to
physical examination and patient-reported questionnaires,
we evaluated functional performance, lower extremity
strength and range of motion, and patellar alignment (using
MRI). We analysed group differences with Wilcoxon’s
matched-pairs signed rank tests, and within-group
associations with Spearman’s rank correlations.
Results We included 24 (80%) women with median (IQR)
age of 56 (9) years and BMI of 22.8 (5.9) kg/m2. Individuals
with PFOA reported lower quality of life (8/100 points lower
EQ-5D-5L, p=0.02), and performed worse on two functional
tests: repeated one-leg rises (median 16 fewer rises,
p=0.04) and timed stair climb (1.2 s slower, p=0.03). There
were no differences in strength tests performed or range of
motion. Patellar proximal translation correlated with worse
functional performance and worse patient-reported pain,
function and self-efficacy, while lateral translation and
lateral tilt correlated with worse knee-related quality of life
(Spearman’s r ranging from 0.5 to 0.7).
Conclusion Functional performance was worse in
individuals with PFOA, despite those individuals having no
significant differences on lower extremity strength testing.
Patellofemoral alignment was associated with worse
functional performance as well as worse patient-reported




(OA) is present in approximately half of mid-
dle-aged and older individuals with knee pain
or tibiofemoral OA1 and is associated with
substantial pain2–5 loss of physical function2
and reduced quality of life6 Isolated patellofe-
moral OA commonly progresses to tibiofe-
moral (or whole knee) OA7 8 Thus, the
patellofemoral joint is a compelling target
for knee OA research and management.
Clinical features of patellofemoral pain,
and knee OA of predominantly tibiofemoral
involvement, are well known9 10 but less is
known about patellofemoral OA, particularly
in comparison to asymptomatic individuals.
Almost exclusively, single studies have
reported individuals with patellofemoral OA
(compared to controls) have: reduced func-
tion (Timed Up and Go)11 weaker hip abduc-
tion and extension but comparable hip
external rotation strength12 13 lower quadri-
ceps strength12 smaller hip and quadriceps
muscle volume14 15 worse patient-reported
pain and function (Knee injury and Osteoar-
thritis Outcome Score, KOOS)16 altered pel-
vic and hip kinematics during gait (greater
anterior and lateral pelvic tilt, greater hip
adduction, lower hip extension)17 lower hip
muscle activity during gait18 and reduced
ankle dorsiflexion range of motion (ROM)
but greater foot mobility with no difference
in frontal plane knee alignment during single
leg squats19 Several studies have reported
greater lateral patellar tilt, lateral translation,
and proximal translation in individuals with
patellofemoral OA compared to asymptomatic
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What are the new findings
► We explored a broad spectrum of clinical features
within a sample of individuals with PFOA compared
to individually-matched controls, including: physical
examination, patient-reported questionnaires,
functional performance, strength, range of motion,
and patellofemoral joint alignment.
► Functional performance was worse in individuals
with PFOA despite no differences in strength
testing or range of motion, compared to controls.
► Patellofemoral alignment differed between
individuals with PFOA and controls, and also
correlated with functional performance and patient-
reported pain, function, quality of life, and knee-
related self-efficacy.
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controls20–22With the exceptionof hip strength12 13 no two
studies have yet to evaluate the same clinical features (phy-
sical exam, strength, ROM, functional performance), and
no study has yet reported on a spectrum of clinical features
together in one sample, or associations among such fea-
tures. A more complete clinical picture of patellofemoral
OA would inform clinical research aimed ultimately at
primary and secondary knee OA prevention and
treatment.
We aimed to describe and compare a wide range of
clinical characteristics (physical examination, functional
performance, strength, range of motion, and patellofe-
moral alignment) in individuals with patellofemoral OA
to individually-matched controls. Our secondary aim was
to explore associations between functional performance
and patient-reported symptoms with patellofemoral align-
ment, as a possible mechanism underlying patellofemoral
OA-related pain, loss of function, and quality of life.
METHODS
Participants
This cross-sectional pilot study reports clinical data
acquired during a previous MRI (MRI) study in the
same sample20 23 For the primary study, we recruited 15
individuals with patellofemoral OA and 15 individually-
matched asymptomatic controls (see table 1 for eligibility
criteria). Controls were matched to patellofemoral OA
cases on age (within 5 years), sex, ethnicity, body mass
index (BMI, within 5 kg/m2), and current physical activ-
ity level (low, moderate or high according to the Interna-
tional Physical Activity Questionnaire-Short, IPAQ-S)24
The study was approved by the University of British
Columbia’s Clinical Research Ethics Board (ID H13-
01993). All participants provided written, informed
consent.
Patient and public involvement
During protocol development and study design, we con-
sulted with a variety of clinicians (physiotherapy, radiol-
ogy, orthopaedists) through Grand Rounds and in-clinic
presentations and discussions. Patients were not directly
involved in study design.
Clinical outcome measures
For participants with patellofemoral OA, we evaluated the
painful knee, or most painful knee if pain was bilateral.
For controls, we evaluated the knee with the same leg
dominance as each matched case. All clinical tests are
listed below, and are described in further detail in online
supplemental table 1.
Patient-reported outcome measures
Participants with patellofemoral OA completed four
patient-reported outcome measures: KOOS (Symptoms,
Table 1 Eligibility criteria
Patellofemoral OA (n=15) Controls (n=15)
Inclusion
► Aged ≥40 years. ► Aged ≥40 years.
► Peri- or retro-patellar knee pain. ► Asymptomatic for >1 year.
► Pain aggravated by ≥1 activity that increases
patellofemoral joint load (eg, squatting).
► Pain rated ≥3/10 on numeric pain rating scale.
► Pain on most days of previous month.
► At least doubtful patellofemoral osteophytes on skyline or
lateral view radiographs, confirmed by a musculoskeletal
radiologist (ie, KL Grade ≥1).
Exclusion
► Pain elsewhere in the knee, hips, ankles, feet, or lumbar
spine.
► Any lower-limb symptoms in the past year.
► Knee or hip arthroplasty, osteotomy, reconstruction,
meniscectomy, fracture; history of major traumatic knee
injury requiring non-weightbearing for ≥24 hour (eg,
dislocation, complete ligament rupture).
► Knee or hip arthroplasty, osteotomy, reconstruction,
meniscectomy, fracture; history of major traumatic knee
injury requiring non-weightbearing for ≥24 hour (eg,
dislocation, complete ligament rupture).
► BMI ≥35 kg/m2. ► BMI ≥35 kg/m2.
► Planned lower-limb surgery in the following 6 months. ► Planned lower-limb surgery in the following 6 months.
► Knee injections in the past 3 months. ► Knee injections in the past 3 months.
► Contraindications to imaging. ► Contraindications to imaging.
► Inability to understand written and spoken English. ► Inability to understand written and spoken English.
► Tibiofemoral joint OA severity of KL grade 3 or 4, or worseOA
severity at the tibiofemoral joint than the patellofemoral joint.
Controls were individually matched to patellofemoral OA cases on age, sex, ethnicity, BMI, and current physical activity level.
BMI, Body mass index; KL, Kellgren and Lawrence; OA, Osteoarthritis; OA classification criteria.
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Pain, Activities of Daily Living, Sport andRecreation,Qual-
ity of Life and Patellofemoral subscales)25 26 Anterior Knee
Pain Scale (AKPS)27 Tampa Scale of Kinesiophobia28 and
Knee Self-Efficacy Scale (K-SES)29 Both groups completed
the Euro-Quality of Life 5-Dimension, 5-Likert scale
(EQ5D-5L)30 Participants reported whether they currently
felt grinding in their knee31 had a history of anterior knee
pain31 had a history of knee swelling32 current medication
use, smoking history, and whether they had been diag-
nosed withOA in other joints in the body. These questions
were asked to estimate comorbidity.
Physical examination
We performed the following physical examination tests:
swipe test (swelling)33; Beighton tests for generalised
hypermobility34; tibiofemoral frontal plane alignment
(inclinometer method)35; and Herrington’s test of med-
iolateral patellar positioning.36
Performance-based tests
Participants performed: the 30-second chair stand test
(maximum number of sit-to-stands in 30 s)37; repeated
one leg rise test (maximum number of one legged sit-to-
stands, to a metronome, to a maximum of 50
repetitions)38; and 12-step timed stair climb test (time to
ascend and descend 12 steps)37
Participants performed five repetitions of a single leg
squat to 45° knee flexion that was filmed (Sony HDR-
CX580V digital HD video recorder) in the frontal plane
to estimate 2D planar alignment at the pelvis, hip and
knee39 40 We used the average of three successful trials
(ie, the participant squatted to target and returned to full
standing without the free foot touching the ground, typi-
cally repetitions two through four) to evaluate five align-
ment measures at the targeted angle (45° knee flexion).
Knee frontal plane projection angle is a 2D measure of
dynamic knee valgus (<180°=valgus). Pelvis level is
a measure of the relative heights of the ipsilateral
and contralateral anterior superior iliac spines (ASIS,
>0°=contralateral hip hike). Hip adduction is a measure
of the femur angle relative to the pelvis (<90°=hip adduc-
tion). Dynamic valgus index combines 2D hip adduction
and knee valgus into a composite measure39 Sternal sym-
metry is a measure of how centred the trunk is positioned
relative to the pelvis (<50%=sternal marker is closer to the
ipsilateral ASIS along a line joining the two ASIS markers,
meaning either the trunk is leaned towards the ipsilateral
side or the contralateral pelvis is lower than the ipsilateral
pelvis). All angles were measured using Motion Analysis
Software version 9.9.0.1 (eHAB, Australia).
For ROMwe evaluated themean of two trials using a 12-
inch handheld goniometer: knee extension and flexion;
and hip extension, flexion, internal rotation and external
rotation41We also assessed ankle dorsiflexion with a knee-
to-wall lunge test42 and normalised the distance from
great toe to wall as a percentage of shank length.
We assessed peak isokinetic knee flexion and extension
torques from trials of five repetitions at 60°/s and 180°/s43
(Biodex Multi-Joint System, Shirley, NY). We evaluated
isometric torques (best of three trials, normalised to body
weight) using a digital handheld dynamometer (Lafayette,
IN) for hip extension, internal and external rotation, and
abduction.44
Imaging (patellofemoral alignment)
We measured both traditional supine two-dimensional
(2D) and innovative three-dimensional (3D) patellofe-
moral alignment using MR imaging on two different
scanners20 23 The supine 2D images allow comparison of
our results with previous studies22 and the weightbearing
3D MR images represent a technical advance and more
functionally-relevant position over the traditional 2D
methods20 23 (see below).
To obtain 2D patellofemoral alignment, participants
were scanned in a relaxed supine position in a 3T MR
scanner (sagittal T1-weighted turbo spin echo sequence,
Philips Achieve, Best, NL) using a commercially-available
surface coil3 20 (online supplemental figure 1). This is the
typical way that MR imaging is used to capture patellofe-
moral alignment in the literature22 We measured bisect
offset, patellar tilt angle, and Insall-Salvati ratio (online
supplemental figure 2), because these have been pre-
viously shown to differ in patellofemoral OA20 22
We captured images for 3D alignment in a vertically
open-bore 0.5TMR scanner (sagittal plane, gradient echo
sequence, ParaMed MROpen Genoa, Italy)20 23 Partici-
pants were positioned, fully weightbearing, in a single-leg
squat with 30° of knee flexion—a position that commonly
provokes pain in patients with anterior knee pain45 To
quantify 3D alignment we (i) segmented bones on all
image slices obtained in both the 3T and 0.5T scanners,
(ii) created participant-specific anatomical surface mod-
els using 3T scanner images, (iii) registered the surface
models to the bony outlines from the 0.5T images, and
(iv) calculated alignment using assigned joint coordinate
systems20 23 We measured patellar lateral translation,
mediolateral tilt, and proximal translation because they
are the weightbearing 3D equivalents of the 2D alignment
measures included in this study. More detailed image
acquisition protocols are described elsewhere20 23
Statistical analyses
We described all participant demographics and examina-
tion findings separately by group (patellofemoral OA and
control), as proportions or as median (IQR, IQR) due to
the relatively small sample sizes in each group. To com-
pare groups, we compared dichotomous outcomes as
proportions using McNemar’s ᵡ² test. We compared con-
tinuous variables between the two groups using Wilcox-
on’s matched-pairs signed rank tests. To calculate
standardised effect sizes (d), we first confirmed normal
distribution of the paired difference scores (Shapiro-Wilk
tests), and then calculated d as mean/SD (SD) of the
difference between matched pairs. This method is similar
to Cohen’s d but accounts for individual matching. We
considered a small effect size d ≥ |0.2|, moderate as d ≥ |
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0.5|, and large as d ≥ |0.8|46 and considered a moderate
effect size to be potentially clinical relevant. Finally, we
explored correlations between functional performance
tests and patellofemoral alignment (both 2D and 3D) in
all participants (n=30), and correlations between patient-
reported outcomes and patellofemoral alignment in the
patellofemoral OA group (n=15). For these analyses, we
used Spearman’s rank correlation coefficients, and
defined correlations as moderate with r ≥ |0.40|, strong
r ≥ |0.6|, and very strong r ≥ |0.80|47 We considered
a moderate correlation to be potentially clinical relevant.
Statistical significance was set at p≤0.05. All statistical
analyses were completed using Stata Inter-cooled version
13.1 (StataCorp, Texas, USA).
RESULTS
Participant characteristics and patient-reported outcomes
The study sample included 24 (80%) women and 6 (20%)
men, and median (IQR) age was 56 (9) years, BMI was
22.8 (5.9) kg/m2 (see table 2). Most of the sample
reported being moderately or highly physically active in
the previous week, with three participants (two with patel-
lofemoral OA) reporting having been sedentary in the
previous week. Twelve pairs were of white/European eth-
nicity, two pairs were of Chinese ethnicity, and one pair
was of Indian and mixed Indian/Asian ethnicity. The
entire sample reported being current non-smokers, and
only two participants reported a smoking history, both
controls (one 7.5 pack-year history, one 30 pack-year
history, both quit approximately 15 years previously).
The individuals with patellofemoral OA reported tak-
ing a total of 19 prescriptionmedications, all unrelated to
OA symptoms (eg, the most common prescription was
synthroid): seven were taking no medications, five were
taking one or two medications, one was taking three
medications, and two were taking five medications. The
control group reported taking a total of 10 prescription
medications: seven were taking no medications, and the
remaining eight were each taking one or two medica-
tions. Ten of the patellofemoral OA participants, and no
controls, reported symptomatic OA in other joints, speci-
fically eight (53%) in the contralateral knee, and three
(20%) in the hands/fingers.
A higher proportion of participants with patellofemoral
OA reported grinding in their knees, a history of anterior
knee pain, and a history of dramatic swelling in the knee
(table 3). Quality of life was significantly worse in the
patellofemoral OA group, with large effect sizes (median
8 [IQR 20] points lower on the EQ-5D-5L VAS, |d|=1.0).
Physical examination
A higher proportion of participants with patellofemoral
OA had a positive swipe test (indicating knee swelling)
than control participants (table 3). Beighton scores were
low overall and did not differ significantly between
groups. Clinical tibiofemoral frontal plane alignment
was more valgus in the patellofemoral OA group, with
a moderate effect size (1.5 [3.5]° more valgus, |d|=0.6).
Herrington’s test of mediolateral patellar position
showed patellae were more laterally displaced in the
patellofemoral OA group, with a large effect size (0.1
[0.2] larger medial to lateral ratio, |d|=0.9).
Performance-based tests
Two functional tests—repeated one leg rises and timed stair
climb—differed significantly between groups (table 4). Spe-
cifically, participants with patellofemoral OA performed 16
(42) fewer repeated one-leg rises compared to controls, and
they navigated stairs 1.2 (4.0) seconds more slowly (both
were moderate effect sizes, |d|=0.6). All remaining func-
tional performance tests, range of motion, and strength
tests revealed no between-group differences. Frontal plane
dynamic alignment during a single-leg squat also did not
differ between groups at the trunk, pelvis, hip or knee.
However, a higher proportion of individuals with patellofe-
moral OA (77% vs controls 38%) reported perceiving the
task’s effort to be hard or markedly hard.
Patellofemoral alignment
Bisect offset was 7 (27) % larger, indicating greater lateral
displacement in individuals with patellofemoral OA com-
pared to controls (moderate effect size, |d|=0.6, table 5). 3D
mediolateral tilt revealed individuals with patellofemoral
OA had 6 (12) ° more lateral patellar tilt than controls
(moderate effect size, |d|=0.7). Effect sizes were also moder-
ate for greater 2Dpatellar tilt angle (5 [12] °more lateral tilt,
|d|=0.5) and 3D proximal translation (8 [27] mm, |d|=0.5),
but these did not reach statistical significance.
The most frequent correlations between alignment
and patient-reported outcomes or function was for 3D
proximal patellar translation in weightbearing (table 6).
Proximal translation was significantly associated with the
following patient-reported outcomes: KOOS Pain
(strong correlation, r=−0.63), AKPS (moderate correla-
tion, r=−0.58), and K-SES Daily Activities subscale
(strong correlation, r=−0.69). Proximal translation was
also moderately correlated with the KOOS Activities of
Daily Living (r=−0.49) and Patellofemoral (r=0.41) sub-
scales, and the K-SES Sport & Leisure (r=−0.49) and
Physical Activities (r=−0.48) subscales, but these did
not reach statistical significance. Proximal translation
was also the only measure that was significantly corre-
lated with any functional performance tests: repeated
one-leg rises (moderate correlation, r=−0.48) and
timed stair climb (moderate correlation, r=0.48).
Table 2 Patient demographics
Patellofemoral OA Controls
Women, n (%) 12 (80%) 12 (80%)
Age, years 54 (10) 56 (8)
BMI, kg/m2 22.64 (7.95) 23.32 (5.93)
Physical activity past
week, hours
5.30 (4.75) 7.50 (7.94)
All values are median (IQR) unless otherwise noted.
BMI, Body mass index; OA, Osteoarthritis.
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Of the remaining alignment measures, greater lateral
translation and lateral patellar tilt (as evaluated by both
2D and 3D measures) were significantly correlated
with worse KOOS Quality of Life (moderate to strong
effect sizes, |r| ranging from 0.52–0.65). These align-
ment measures were also moderately correlated with
other patient-reported outcomes, but no discernable
pattern of association emerged. Insall-Salvati ratio was
not correlated with any patient-reported outcomes or
functional tests.
DISCUSSION
In this pilot study, we found significant differences in
patient-reported outcomes, functional performance
tests, and patellofemoral alignment. Specifically, indivi-
duals with patellofemoral OA reported worse health-
related quality of life, greater likelihood of crepitus and
history of anterior knee pain and swelling, all of which are
consistent with findings previously reported6 31 32 48 Indi-
viduals performed worse on two of three functional per-
formance tests compared to controls. Patellofemoral
alignment differed between groups on several measures:
(i) 2D supineMR images (larger bisect offset, OA group),
(ii) 3D weightbearing MR images (greater lateral tilt, OA
group); and (iii) clinical measures (greater tibiofemoral
valgus and lateral patellar displacement, OA group). All
significant effect sizes (d) were at least moderate, suggest-
ing possible clinical importance. These results can be
used to inform future hypotheses and point to associa-
tions that may be clinically meaningful, thus guiding
selection of outcome measures in future studies. These
results also provide estimates for sample sizes calculations
for future studies. For example, based on our stair climb
test results, a sample size of 36 per group would be needed





Reported crepitus n (%) 9 (60%) 0 (0%) <0.01
History of anterior knee pain n (%) 15 (100%) 4 (26.7%) <0.01
History of swelling n (%) 11 (73%) 0 (0%) <0.01
Swipe test positive n (%) 8 (53%) 3 (20%) 0.06
Beighton score/9 0 (1) 1 (1) −1 (1) 0.5 0.06
Tibiofemoral frontal plane alignment (°) −1.0 (2.5)* −0.5 (2)* −1.5 (3.5) 0.6 0.03
Herrington test of mediolateral patellar
positioning (M:L ratio)
1.19 (0.26) 1.07 (0.14) 0.11 (0.15) 0.9 0.01
EQ-5D-5L
Index score 0.885 (0.044) 0.949 (0.00) −0.06 (0.04) 1.0 <0.01
VAS 85 (10) 91 (10) −8 (20) 0.8 0.02
KOOS
Symptoms 71.4 (28.6) – –
Pain 75.0 (16.7) – –
Activities of Daily
Living
83.8 (20.6) – –
Sport and Recreation 50.0 (45.0) – –
Quality of Life 56.3 (31.3) – –
Patellofemoral 56.8 (22.7) – –
AKPS 74 (22) – –
Tampa Scale for Kinesiophobia





Daily Activities 84.3 (25.7) – –
Sport and Leisure 72 (28) – –
Physical Activities 51.7 (31.3) – –
Knee Function in the Future 53.3 (33.3) – –
*<0° is valgus alignment.
Bold indicates at least a moderate effect size between groups, or statistical significance.
All scores are median (IQR) unless otherwise stated.
AKPS, Anterior Knee Pain Scale (varies from zero, maximum problems, to 100, no problems); |d|, Standardised effect size; EQ-5D-5L, EuroQol
Health Status Measure-5 dimension-5-likert: Index provides a Canadian-specific adjusted score combining all 5 dimensions (scores from zero
[dead] to 1.000 [perfect health]), and VAS (visual analogue scale) is a single overall self-reported evaluation that varies from zero (dead) to 100
(perfect health); KOOS, Knee injury and Osteoarthritis Outcome Score (varies from zero, maximum problems, to 100, no problems); IQR,
Interquartile range; OA, Osteoarthritis; M:L, Medial to lateral.
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to achieve power of 0.80 and α of 0.05 to detect between-
group differences.
We did not detect muscle weakness in individuals with
patellofemoral OA, despite reduced functional perfor-
mance. This differs from a previous study where, com-
pared to healthy controls, eight individuals with
patellofemoral OA had lower quadriceps strength and
lower hip abduction and extension strength, but similar
external rotation strength12 and another study where 15
individuals with patellofemoral OA had lower hip abduc-
tion strength but similar external rotation strength13
A possible explanation is that we matched controls on
physical activity, whereas previous studies did not. Their
findings may thus reflect deconditioning secondary to
OA-related reductions in physical activity.
While muscle strength is one possible factor explain-
ing functional performance, other factors may
include: (i) pain avoidance or compensatory strategies
(similar to antalgic gait patterns); (ii) psychological
reluctance or lack of confidence to perform function-
ally demanding tasks; or (iii) differences in knee geo-
metry. This latter point is supported by findings in our






30 s chair stand test (n) 14 (2) 14 (6) 0 (6) 0.4 0.22
Repetitive one leg rises (n) 4 (34) 28 (34) −16 (42) 0.6 0.04
Timed 12 stair climb (s) 10.1 (3.0) 8.9 (1.6) 1.2 (4.0) 0.6 0.03
Range of motion
Ankle dorsiflexion/shank length (%) 24.0 (8.4) 30.6 (11.2) −4.8 (17.3) 0.4 0.12
Knee hyperextension (°) 2.0 (6.0) 3.5 (4.0) −2.5 (8.0) 0.4 0.14
Knee flexion (°) 137.5 (13.0) 135.0 (10.0) 0.0 (7.0) 0.1 0.73
Hip extension (°) 16.5 (8.0) 17.0 (8.0) 1.0 (5.0) 0.1 0.95
Hip flexion (°) 119.0 (24.0) 125.5 (16.0) −1.0 (25.5) 0.3 0.39
Hip internal rotation (°) 39.0 (20.0) 36.5 (10.5) −4.0 (19.0) 0.1 0.78
Hip external rotation (°) 44.0 (12.0) 48.5 (14.0) −1.5 (19.5) 0.0 0.93
Isokinetic strength
Knee extension peak torque, 60°/s
(% normalised to BW)
145.6 (71.8) 175.2 (85.3) −16.1 (161.3) 0.4 0.21
Knee extension peak torque, 180°/s
(% normalised to BW)
105.1 (53.6) 127.9 (46.5) −22.8 (93.3) 0.4 0.19
Knee flexion peak torque, 60°/s (% normalised
to BW)
89.6 (28.2) 94.8 (32.2) 3.7 (41.1) 0.2 0.86
Knee flexion peak torque, 180°/s (% normalised
to BW)
66.3 (24.3) 70.3 (31.8) 0.7 (28.5) 0.4 0.36
Isometric strength
Hip extension (Nm/kg) 1.2 (0.5) 1.5 (0.4) −0.3 (1.0) 0.2 0.64
Hip abduction (Nm/kg) 1.2 (0.4) 1.4 (0.7) −0.3 (0.5) 0.4 0.22
Hip internal rotation (Nm/kg) 0.4 (0.3) 0.4 (0.4) 0.0 (0.5) 0.1 0.98
Hip external rotation (Nm/kg) 0.5 (0.2) 0.6 (0.4) −0.1 (0.4) 0.2 0.47
Single leg squats 2D angles
Knee abduction (°)* 174.3 (6.2) 173.9 (9.0) −0.6 (12.6) 0.1 0.68
Pelvis level (°)† 1.2 (5.0) 1.9 (1.3) −0.4 (4.8) 0.4 0.28
Hip adduction (°)‡ 79.1 (7.1) 80.4 (7.7) −0.5 (9.9) 0.1 0.75
Dynamic valgus index§ 18.6 (14.0) 14.5 (14.4) 2.2 (22.5) 0.0 0.92
Sternal symmetry¶ 41.2 (9.8) 43.5 (11.2) −3.1 (17.5) 0.3 0.39
Perceived effort hard or very hard n (%) 10 (77%) 5 (38%) 0.05
*Angles <180°=valgus.
†Larger value=less contralateral hip drop.
‡Larger value=less hip adduction.
§Larger value=more combined hip adduction and knee valgus.
¶Horizontal distance of (ipsilateral anterior superior iliac spine, ASIS, to sternal marker) as a percentage of (contralateral ASIS to sternal marker),
<50%=ipsilateral trunk lean or contralateral hipdrop.
BW, Body weight; |d|=Standardised effect size; IQR, IQR; OA, osteoarthritis.
Bold indicates at least a moderate effect size between groups, or statistical significance.
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study that 3D patellar proximal translation correlated
with worse functional performance, and worse patient-
reported pain, function and self-efficacy in the patel-
lofemoral OA group. A higher positioned patella
could impair functional performance because it
reduces contact area (resulting in greater joint contact
forces and possibly more pain), or because the change
in alignment negatively impacts the effective moment
Table 6 Spearman’s rank correlations between patient-reported outcomes, function and key patellofemoral alignment
measures













r P r P r P r P r P r P
Patient-reported outcomes
KOOS (n=15)†
Symptoms −0.24 0.39 −0.45 0.09 −0.34 0.22 0.23 0.41 −0.43 0.11 −0.48 0.07
Pain −0.63 0.01 −0.31 0.27 −0.35 0.20 −0.03 0.93 −0.15 0.60 −0.11 0.68
Activities of Daily Living −0.49 0.06 −0.22 0.41 −0.28 0.31 0.15 0.59 −0.03 0.93 −0.24 0.40
Sport and Recreation −0.38 0.16 −0.39 0.16 −0.40 0.14 −0.11 0.70 −0.37 0.18 −0.36 0.18
Quality of Life −0.20 0.47 −0.63 0.01 −0.52 0.05 −0.01 0.98 −0.57 0.03 −0.65 <0.01
Patellofemoral −0.41 0.13 −0.28 0.31 −0.23 0.42 −0.08 0.77 −0.24 0.40 −0.30 0.27
AKPS (n=15) −0.58 0.02 −0.41 0.13 −0.50 0.06 0.09 0.75 −0.30 0.28 −0.36 0.19
Tampa Scale for
Kinesiophobia (n=15)
0.21 0.44 −0.01 0.98 0.08 0.77 0.19 0.49 −0.22 0.42 −0.26 0.36
Knee Self-Efficacy Scale
(n=15)
Daily Activities −0.69 <0.01 −0.20 0.47 −0.34 0.22 −0.22 0.44 −0.10 0.72 0.01 0.98
Sport & Leisure −0.49 0.06 0.03 0.91 −0.01 0.97 0.09 0.75 0.26 0.35 0.13 0.65
Physical Activities −0.48 0.07 −0.39 0.15 −0.45 0.09 −0.06 0.83 −0.19 0.49 −0.16 0.57
Knee Function in the Future −0.20 0.47 −0.20 0.48 −0.28 0.32 0.38 0.16 0.05 0.85 0.03 0.93
EQ-5D-5L (n=30) −0.37 0.04 0.02 0.93 −0.31 0.10 −0.42 0.02 −0.49 <0.01 −0.35 0.06
Functional performance
(n=30)
30 s chair stand test −0.19 0.31 −0.02 0.94 0.09 0.63 −0.04 0.85 0.16 0.39 0.08 0.68
Repetitive single leg rises −0.48 <0.01 −0.07 0.72 −0.18 0.34 −0.32 0.09 −0.24 0.21 −0.22 0.24
Timed 12 stair climb −0.48 <0.01 0.16 0.41 −0.15 0.43 −0.33 0.07 −0.03 0.88 0.06 0.77
†Only participants with patellofemoral osteoarthritis completed knee-related patient-reported outcomes (n=15); all remaining comparisons are
for the full sample (n=30).
Items in bold indicate moderate correlation (r ≥0.40), or statistical significance (p≤0.05).
Correlation signs have all been standardised to reflect that a ‘–’ sign indicates that as the patella moves further into malalignment (ie, more
proximally, more laterally, or more lateral tilt), the outcome of interest worsens.
AKPS, Anterior Knee Pain Scale; EQ-5D-5L, Euro-Quality of Life 5-Dimension, 5-Likert scale; KOOS, Knee injury and Osteoarthritis Outcome
Score; PFOA, Patellofemoral osteoarthritis.
Table 5 Patellofemoral alignment on imaging
Patellofemoral OA Control Paired difference |d| P
2D alignment, supine near full extension
Insall-Salvati ratio 1.18 (0.15) 1.10 (0.31) 0.07 (0.47) 0.4 0.16
Bisect offset (%) 60.8 (26.2) 52.5 (6.5) 6.6 (27.5) 0.6 0.05
Patellar tilt angle (°) 14.3 (9.9) 9.5 (6.6) 5.5 (12.1) 0.5 0.08
3D alignment, single leg squat 30° flexion
Proximal translation (mm) 18.5 (15.1) 11.9 (15.9) 7.5 (26.9) 0.5 0.11
Lateral translation (mm) 0.4 (9.8) −1.8 (4.1) 2.3 (8.2) 0.4 0.19
Medial tilt (°)* 14.5 (6.3) 18.1 (10.0) −5.9 (11.9) 0.7 0.02
*3D measure of tilt the value is reported as medial tilt, so a smaller value indicates greater lateral tilt.
All values reported as median (IQR) unless otherwise stated.
Bold indicates at least a moderate effect size between groups, or statistical significance.
|d|, Standardised effect size; IQR, Interquartile range; OA, Osteoarthritis.
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arm, resulting in decreased force generation about the
knee.49
Interestingly, worse clinical outcomeswere associatedwith
3D proximal patellar translation but not 2D Insall Salvati
ratio, which is designed to identify patella alta50 The Insall
Salvati ratio may be less sensitive because it is a 2D proxy
measure for a more complex, 3D patellar position. Alterna-
tively, it may be because the 2D measure was of a relaxed
knee. In weightbearing, patellofemoral joint contact forces
are higher, and active quadriceps may cause further prox-
imal translation, both possibly contributing to worse
symptoms.
Increased patellar lateral translation and lateral tilt (in
both 2D and 3D) were related to worse patient-reported
knee-related quality of life. This extends previous findings
of lateral translation 1 year after anterior cruciate liga-
ment reconstruction predicting reduced KOOS Quality
of Life 5-years post-surgery51 These findings warrant
further investigation, particularly because alignment
may be modifiable through treatments such as taping
and bracing.52–54
The only functional test that did not differ between
groups was the timed chair stand, a recommended test
for whole-knee OA37 This task is less demanding than
single leg rises and stair climbing. Our results suggest
this test may have a ceiling effect in physically active
individuals with predominantly patellofemoral OA.
More demanding tasks such as the repeated one-leg
rise, in addition to recommended core outcome sets,
may improve sensitivity for detecting early functional
decline when evaluating individuals with patellofemoral
OA, who may represent an earlier stage of knee OA.
The primary limitation to this study is its small sample size.
While individual-matching-reduced confounding, this was
nonetheless a pilot study that is underpowered for confir-
matory analyses. We intentionally evaluated a wide range of
clinical characteristics, which is a strength of the study given
how little is known about patellofemoral OA. However, on
account of this being an exploratory study design, and thus
hypothesis-generating, we did not adjust for multiple
testing55 Doing so can reduce the likelihood of spurious
findings (Type I errors), but this occurs at the expense of
increasing the likelihoodof falsenegatives (Type II errors)55
The results of this pilot study should therefore be consid-
ered within this context, and in addition to p-values, effect
sizes and direction of effects should be considered to iden-
tify potentially interesting findings that can be confirmed in
future larger studies. A third limitation is that patient-
reported physical activity is prone to bias56 which may have
introduced error into our matching methods. Finally, while
our methods for evaluating hip strength have adequate
reliability44 we are unable to assess for specific hip muscle
weakness. Having said this, previous studies found that all
hip abductormuscles had smaller volume in patellofemoral
OA compared to controls, suggesting that any hip weakness
may be generalised rather than selective.14
CONCLUSIONS
Our study identified a variety of clinical features that dif-
fered in individuals with patellofemoral OA compared to
individually-matched controls. Most notably, functional per-
formance was worse in individuals with patellofemoral OA,
despite no significant differences in strength testing. Patel-
lofemoral malalignment was associated with worse func-
tional performance and self-reported pain, function and
quality of life. Alignment is thus a possible mechanism
underpinning patellofemoral OA symptoms, and because
alignment is modifiable52–54 this warrants further investiga-
tion. Overall, our findings inform future studies ultimately
aimed at improving clinical management of patellofe-
moral OA.
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